These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 37167953)

  • 1. Key determinants of success in fecal microbiota transplantation: From microbiome to clinic.
    Porcari S; Benech N; Valles-Colomer M; Segata N; Gasbarrini A; Cammarota G; Sokol H; Ianiro G
    Cell Host Microbe; 2023 May; 31(5):712-733. PubMed ID: 37167953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.
    Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC
    Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation.
    Staley C; Kaiser T; Vaughn BP; Graiziger CT; Hamilton MJ; Rehman TU; Song K; Khoruts A; Sadowsky MJ
    Microbiome; 2018 Sep; 6(1):166. PubMed ID: 30227892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Super-Donor Phenomenon in Fecal Microbiota Transplantation.
    Wilson BC; Vatanen T; Cutfield WS; O'Sullivan JM
    Front Cell Infect Microbiol; 2019; 9():2. PubMed ID: 30719428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection.
    Lee PC; Chang TE; Wang YP; Lee KC; Lin YT; Chiou JJ; Huang CW; Yang UC; Li FY; Huang HC; Wu CY; Huang YH; Hou MC
    J Formos Med Assoc; 2022 Sep; 121(9):1636-1646. PubMed ID: 34836663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation.
    Smillie CS; Sauk J; Gevers D; Friedman J; Sung J; Youngster I; Hohmann EL; Staley C; Khoruts A; Sadowsky MJ; Allegretti JR; Smith MB; Xavier RJ; Alm EJ
    Cell Host Microbe; 2018 Feb; 23(2):229-240.e5. PubMed ID: 29447696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-generational bacterial strain transfer to an infant after fecal microbiota transplantation to a pregnant patient: a case report.
    Wei S; Jespersen ML; Baunwall SMD; Myers PN; Smith EM; Dahlerup JF; Rasmussen S; Nielsen HB; Licht TR; Bahl MI; Hvas CL
    Microbiome; 2022 Nov; 10(1):193. PubMed ID: 36352460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases.
    Ianiro G; Punčochář M; Karcher N; Porcari S; Armanini F; Asnicar F; Beghini F; Blanco-Míguez A; Cumbo F; Manghi P; Pinto F; Masucci L; Quaranta G; De Giorgi S; Sciumè GD; Bibbò S; Del Chierico F; Putignani L; Sanguinetti M; Gasbarrini A; Valles-Colomer M; Cammarota G; Segata N
    Nat Med; 2022 Sep; 28(9):1913-1923. PubMed ID: 36109637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal microbiota transplantation for treatment of patients with recurrent
    Voth E; Khanna S
    Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precise quantification of bacterial strains after fecal microbiota transplantation delineates long-term engraftment and explains outcomes.
    Aggarwala V; Mogno I; Li Z; Yang C; Britton GJ; Chen-Liaw A; Mitcham J; Bongers G; Gevers D; Clemente JC; Colombel JF; Grinspan A; Faith J
    Nat Microbiol; 2021 Oct; 6(10):1309-1318. PubMed ID: 34580445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments.
    Rasmussen TS; Mao X; Forster S; Larsen SB; Von Münchow A; Tranæs KD; Brunse A; Larsen F; Mejia JLC; Adamberg S; Hansen AK; Adamberg K; Hansen CHF; Nielsen DS
    Microbiome; 2024 Jul; 12(1):119. PubMed ID: 38951925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation.
    He R; Li P; Wang J; Cui B; Zhang F; Zhao F
    Gut Microbes; 2022; 14(1):2100197. PubMed ID: 35854629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in IgA-targeted microbiota following fecal transplantation for recurrent
    Huus KE; Frankowski M; Pučić-Baković M; Vučković F; Lauc G; Mullish BH; Marchesi JR; Monaghan TM; Kao D; Finlay BB
    Gut Microbes; 2021; 13(1):1-12. PubMed ID: 33382360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Infectious Diseases Perspective on Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children.
    Cotter JM; Nicholson MR; Kociolek LK
    J Pediatric Infect Dis Soc; 2019 Dec; 8(6):580-584. PubMed ID: 31550348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent
    Wei S; Bahl MI; Baunwall SMD; Dahlerup JF; Hvas CL; Licht TR
    Gut Microbes; 2022; 14(1):2084306. PubMed ID: 36519447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
    Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Evolving Landscape of Fecal Microbial Transplantation.
    Shao T; Hsu R; Hacein-Bey C; Zhang W; Gao L; Kurth MJ; Zhao H; Shuai Z; Leung PSC
    Clin Rev Allergy Immunol; 2023 Oct; 65(2):101-120. PubMed ID: 36757537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile.
    Jan N; Hays RA; Oakland DN; Kumar P; Ramakrishnan G; Behm BW; Petri WA; Marie C
    mSphere; 2021 Oct; 6(5):e0066921. PubMed ID: 34704776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal microbiota transplantation: a review on current formulations in
    Rakotonirina A; Galperine T; Allémann E
    Expert Opin Biol Ther; 2022 Jul; 22(7):929-944. PubMed ID: 35763604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.